SWKH News and Press, SWK Holdings Corporation From 05/04/22

Enteris BioPharma to Exhibit at CPhI North America 2022 PR Newswire BOONTON, N.J. , May 4, 2022 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a...

Profiting from the index’s reconstitution. Identifying the cutoff. Identifying surprise new members. For further details see: Killer R2K Setup In SWK

Enteris BioPharma Announces Acceptance of Two Abstracts for Presentation at ENDO 2022 Annual Conference PR Newswire BOONTON, N.J. , April 12, 2022 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products ba...

Enteris BioPharma Highlighted as Game Changer in Drug Development & Delivery Special Feature on Innovative Technologies for Improving Drug Solubility and Bioavailability Enteris BioPharma Highlighted as Game Changer in Drug Development & Delivery Special Feature on Innov...

SWK Holdings Corporation (SWKH) Q4 2021 Earnings Conference Call March 28, 2022 10:00 A.M. ET Company Participants Jason Rando - Executive Vice President & Chief Operating Officer, Tiberend Strategic Advisors, Inc. Winston Black - Chairman and Chief Executive Officer Presentation Operator...

SWK Holdings press release (NASDAQ:SWKH): Q4 GAAP EPS of $0.49 misses by $0.03. Revenue of $15M (+37.6% Y/Y) beats by $1.2M. For further details see: SWK Holdings GAAP EPS of $0.49 misses by $0.03, revenue of $15M beats by $1.2M

SWK Holdings Corporation Announces Financial Results for Fourth Quarter and Full-Year 2021 PR Newswire Conference Call and Live Audio Webcast Scheduled for Monday, March 28, 2022, at 10:00 a.m. ET Corporate Highlights Reconstituted Board an...

AOTI Secures Major Expansion Funding from Leading Healthcare Financier PR Newswire OCEANSIDE, Calif. , March 25, 2022 /PRNewswire/ -- Advanced Oxygen Therapy Inc. (AOTI), the global leader in noninvasive topical oxygen wound healing solutions, announced t...

SWK Holdings to Participate in Maxim's 2022 Virtual Growth Conference PR Newswire DALLAS , March 23, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to s...

Enteris BioPharma, a unit of SWK Holdings (NASDAQ:SWKH), announced the publication of a new white paper titled 'HPAPI Drug Solid Oral Dosage (SOD) Manufacturing – Ensuring Content Uniformity.' The paper, co-authored by Thomas Daggs, vice president of product development & quality c...